image
Healthcare - Medical - Instruments & Supplies - NYSE - US
$ 314.49
-6.99 %
$ 22.8 B
Market Cap
47.43
P/E
1. INTRINSIC VALUE

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.[ Read More ]

The intrinsic value of one WST stock under the base case scenario is HIDDEN Compared to the current market price of 314 USD, West Pharmaceutical Services, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart WST

image
FINANCIALS
2.95 B REVENUE
2.18%
676 M OPERATING INCOME
-7.90%
593 M NET INCOME
1.28%
776 M OPERATING CASH FLOW
7.25%
-369 M INVESTING CASH FLOW
-27.93%
-460 M FINANCING CASH FLOW
-56.54%
747 M REVENUE
6.40%
161 M OPERATING INCOME
23.32%
136 M NET INCOME
22.19%
180 M OPERATING CASH FLOW
9.15%
-82.1 M INVESTING CASH FLOW
18.87%
-64.4 M FINANCING CASH FLOW
70.50%
Balance Sheet Decomposition West Pharmaceutical Services, Inc.
image
Current Assets 1.94 B
Cash & Short-Term Investments 854 M
Receivables 512 M
Other Current Assets 570 M
Non-Current Assets 1.89 B
Long-Term Investments 210 M
PP&E 1.51 B
Other Non-Current Assets 171 M
Current Liabilities 672 M
Accounts Payable 242 M
Short-Term Debt 169 M
Other Current Liabilities 260 M
Non-Current Liabilities 277 M
Long-Term Debt 157 M
Other Non-Current Liabilities 119 M
EFFICIENCY
Earnings Waterfall West Pharmaceutical Services, Inc.
image
Revenue 2.95 B
Cost Of Revenue 1.82 B
Gross Profit 1.13 B
Operating Expenses 454 M
Operating Income 676 M
Other Expenses 82.6 M
Net Income 593 M
RATIOS
38.28% GROSS MARGIN
38.28%
22.92% OPERATING MARGIN
22.92%
20.12% NET MARGIN
20.12%
20.60% ROE
20.60%
15.50% ROA
15.50%
17.95% ROIC
17.95%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis West Pharmaceutical Services, Inc.
image
Net Income 593 M
Depreciation & Amortization 137 M
Capital Expenditures -362 M
Stock-Based Compensation 23.3 M
Change in Working Capital -20.4 M
Others -9.9 M
Free Cash Flow 414 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets West Pharmaceutical Services, Inc.
image
Wall Street analysts predict an average 1-year price target for WST of $393 , with forecasts ranging from a low of $250 to a high of $536 .
WST Lowest Price Target Wall Street Target
250 USD -20.51%
WST Average Price Target Wall Street Target
393 USD 24.96%
WST Highest Price Target Wall Street Target
536 USD 70.43%
4. DIVIDEND ANALYSIS
0.07% DIVIDEND YIELD
0.21 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership West Pharmaceutical Services, Inc.
image
Sold
0-3 MONTHS
527 K USD 1
3-6 MONTHS
9.96 M USD 2
6-9 MONTHS
51.1 M USD 5
9-12 MONTHS
707 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 weeks ago
Oct 29, 2024
Sell 148 K USD
Witherspoon Charles
VP & Treasurer
- 478
310.4 USD
2 weeks ago
Oct 29, 2024
Sell 69.8 K USD
Witherspoon Charles
VP & Treasurer
- 225
310.4 USD
2 months ago
Aug 19, 2024
Sell 159 K USD
Witherspoon Charles
VP & Treasurer
- 529
300 USD
2 months ago
Aug 19, 2024
Sell 150 K USD
Witherspoon Charles
VP & Treasurer
- 500
300 USD
6 months ago
May 10, 2024
Sell 226 K USD
Hofmann Thomas W
Director
- 617
365.92 USD
3 months ago
Aug 06, 2024
Sell 9.36 M USD
Green Eric Mark
President, CEO and Board Chair
- 30732
304.712 USD
5 months ago
Jun 12, 2024
Sell 595 K USD
Abraham Silji
SVP, Chief Technology Officer
- 1800
330.78 USD
6 months ago
May 07, 2024
Sell 3.42 M USD
Green Eric Mark
President, CEO and Board Chair
- 9316
366.6419 USD
6 months ago
May 07, 2024
Sell 5.75 M USD
Green Eric Mark
President, CEO and Board Chair
- 15684
366.6589 USD
6 months ago
May 07, 2024
Sell 15 M USD
Green Eric Mark
President, CEO and Board Chair
- 41000
366.6521 USD
8 months ago
Mar 11, 2024
Sell 292 K USD
Winters Chad
VP, Chief Accounting Officer
- 815
358.817 USD
8 months ago
Feb 28, 2024
Sell 724 K USD
Witherspoon Charles
VP & Treasurer
- 2019
358.6238 USD
8 months ago
Feb 27, 2024
Sell 23.1 M USD
Green Eric Mark
President, CEO and Board Chair
- 64132
359.8511 USD
8 months ago
Feb 23, 2024
Sell 2.56 M USD
Abraham Silji
SVP, Chief Technology Officer
- 7012
365 USD
11 months ago
Dec 04, 2023
Sell 354 K USD
Winters Chad
VP, Chief Accounting Officer
- 1013
349.0042 USD
11 months ago
Dec 01, 2023
Sell 354 K USD
Winters Chad
VP, Chief Accounting Officer
- 1013
349.0042 USD
1 year ago
Oct 31, 2023
Sell 192 K USD
Witherspoon Charles
VP & Treasurer
- 594
322.475 USD
1 year ago
Oct 31, 2023
Sell 192 K USD
Witherspoon Charles
VP & Treasurer
- 596
322.27 USD
1 year ago
Aug 30, 2023
Sell 315 K USD
Favorite Annette F
Sr. VP & Chief HR Officer
- 760
414.195 USD
1 year ago
Aug 30, 2023
Sell 514 K USD
Favorite Annette F
Sr. VP & Chief HR Officer
- 1240
414.9102 USD
1 year ago
Aug 22, 2023
Sell 1.37 M USD
Reiss-Clark Cindy
Chief Commercial Officer
- 3477
393.34 USD
1 year ago
Aug 11, 2023
Sell 4.23 M USD
Lai Quintin J
VP Strat & Investor Relations
- 10725
394.6225 USD
1 year ago
Aug 11, 2023
Sell 3.42 M USD
Lai Quintin J
VP Strat & Investor Relations
- 8635
395.5426 USD
1 year ago
Aug 11, 2023
Sell 690 K USD
Lai Quintin J
VP Strat & Investor Relations
- 1741
396.123 USD
1 year ago
Aug 09, 2023
Sell 666 K USD
Witherspoon Charles
VP & Treasurer
- 1680
396.54 USD
1 year ago
Aug 08, 2023
Sell 3.24 M USD
Abraham Silji
SVP, Chief Technology Officer
- 8154
397.1776 USD
1 year ago
Aug 08, 2023
Sell 2.39 K USD
Abraham Silji
SVP, Chief Technology Officer
- 6
397.69 USD
1 year ago
Aug 08, 2023
Sell 390 K USD
Green Eric Mark
President & CEO
- 1000
389.62 USD
1 year ago
Aug 08, 2023
Sell 1.76 M USD
Green Eric Mark
President & CEO
- 4500
392.1553 USD
1 year ago
Aug 08, 2023
Sell 2.77 M USD
Green Eric Mark
President & CEO
- 7055
393.131 USD
1 year ago
Aug 08, 2023
Sell 3.28 M USD
Green Eric Mark
President & CEO
- 8329
394.174 USD
1 year ago
Aug 08, 2023
Sell 3.04 M USD
Green Eric Mark
President & CEO
- 7684
395.0733 USD
1 year ago
Aug 08, 2023
Sell 2.65 M USD
Green Eric Mark
President & CEO
- 6700
396.1253 USD
1 year ago
Aug 08, 2023
Sell 2.99 M USD
Green Eric Mark
President & CEO
- 7532
397.1762 USD
1 year ago
Aug 08, 2023
Sell 438 K USD
Green Eric Mark
President & CEO
- 1100
397.8964 USD
1 year ago
Aug 08, 2023
Sell 39.9 K USD
Green Eric Mark
President & CEO
- 100
398.87 USD
1 year ago
Aug 02, 2023
Sell 8.2 M USD
Birkett Bernard
Sr VP, Chief Fin & Ops Off
- 22134
370.3809 USD
1 year ago
Aug 02, 2023
Sell 74.2 K USD
Birkett Bernard
Sr VP, Chief Fin & Ops Off
- 200
371.025 USD
1 year ago
May 30, 2023
Sell 343 K USD
Witherspoon Charles
VP & Treasurer
- 1000
343.05 USD
1 year ago
May 09, 2023
Sell 5.12 M USD
Green Eric Mark
President & CEO
- 14157
361.9468 USD
1 year ago
May 09, 2023
Sell 4.56 M USD
Green Eric Mark
President & CEO
- 12562
362.9267 USD
1 year ago
May 09, 2023
Sell 4.6 M USD
Green Eric Mark
President & CEO
- 12648
363.9354 USD
1 year ago
May 09, 2023
Sell 1.51 M USD
Green Eric Mark
President & CEO
- 4133
364.7645 USD
1 year ago
May 09, 2023
Sell 183 K USD
Green Eric Mark
President & CEO
- 500
365.458 USD
1 year ago
May 01, 2023
Sell 443 K USD
Hofmann Thomas W
Director
- 1212
365.575 USD
1 year ago
May 01, 2023
Sell 2.69 M USD
Abraham Silji
SVP, Chief Technology Officer
- 7371
365.5532 USD
1 year ago
May 01, 2023
Sell 238 K USD
Abraham Silji
SVP, Chief Technology Officer
- 649
366.1385 USD
1 year ago
May 01, 2023
Sell 3.44 M USD
Favorite Annette F
Sr. VP & Chief HR Officer
- 9425
365.4683 USD
1 year ago
May 01, 2023
Sell 985 K USD
Favorite Annette F
Sr. VP & Chief HR Officer
- 2687
366.4632 USD
1 year ago
May 01, 2023
Sell 331 K USD
Favorite Annette F
Sr. VP & Chief HR Officer
- 900
367.4527 USD
1 year ago
Mar 09, 2023
Sell 484 K USD
Abraham Silji
SVP, Chief Technology Officer
- 1500
322.5667 USD
1 year ago
Mar 07, 2023
Sell 367 K USD
Green Eric Mark
- 1131
324.29 USD
1 year ago
Mar 07, 2023
Sell 1.71 M USD
Green Eric Mark
- 5277
323.3804 USD
1 year ago
Mar 07, 2023
Sell 8.63 M USD
Green Eric Mark
- 26753
322.4874 USD
1 year ago
Mar 07, 2023
Sell 2.47 M USD
Green Eric Mark
- 7685
321.6138 USD
1 year ago
Mar 07, 2023
Sell 1.01 M USD
Green Eric Mark
- 3154
320.6002 USD
1 year ago
Dec 05, 2022
Sell 1.6 M USD
Green Eric Mark
director: President & CEO
- 6746
236.9488 USD
1 year ago
Dec 05, 2022
Sell 2.24 M USD
Green Eric Mark
director: President & CEO
- 9408
237.6676 USD
1 year ago
Dec 05, 2022
Sell 1.51 M USD
Green Eric Mark
director: President & CEO
- 6312
238.8268 USD
1 year ago
Dec 05, 2022
Sell 2.58 M USD
Green Eric Mark
director: President & CEO
- 10752
239.6972 USD
1 year ago
Dec 05, 2022
Sell 2.33 M USD
Green Eric Mark
director: President & CEO
- 9682
240.7328 USD
1 year ago
Dec 05, 2022
Sell 266 K USD
Green Eric Mark
director: President & CEO
- 1100
241.4645 USD
2 years ago
Aug 02, 2022
Sell 378 K USD
Birkett Bernard
director: Sr VP, CFO & COO
- 1100
343.3845 USD
2 years ago
Aug 01, 2022
Sell 1.85 M USD
Abraham Silji
director: Chief Digital & Trans Officer
- 5374
343.9349 USD
2 years ago
Mar 14, 2022
Sell 467 K USD
Lai Quintin J
VP Corp Development & Strategy
- 1271
367.1156 USD
2 years ago
Mar 14, 2022
Sell 149 K USD
Lai Quintin J
VP Corp Development & Strategy
- 405
367.9442 USD
2 years ago
Mar 14, 2022
Sell 464 K USD
Lai Quintin J
VP Corp Development & Strategy
- 1254
369.8575 USD
2 years ago
Mar 14, 2022
Sell 165 K USD
Lai Quintin J
VP Corp Development & Strategy
- 446
370.9431 USD
2 years ago
Mar 14, 2022
Sell 223 K USD
Lai Quintin J
director: VP Corp Development & Strategy
- 600
371.887 USD
2 years ago
Mar 14, 2022
Sell 336 K USD
Lai Quintin J
VP Corp Development & Strategy
- 900
372.924 USD
2 years ago
Mar 14, 2022
Sell 1.1 M USD
Lai Quintin J
VP Corp Development & Strategy
- 2940
374.4492 USD
2 years ago
Mar 14, 2022
Sell 75 K USD
Lai Quintin J
VP Corp Development & Strategy
- 200
374.92 USD
3 years ago
Sep 10, 2021
Sell 2.33 M USD
Lai Quintin J
- 5072
460.1758 USD
3 years ago
Sep 10, 2021
Sell 1.43 M USD
Lai Quintin J
- 3100
460.8045 USD
3 years ago
Sep 10, 2021
Sell 694 K USD
Lai Quintin J
- 1500
462.6306 USD
3 years ago
May 10, 2021
Sell 727 K USD
Abraham Silji
- 2171
335 USD
4 years ago
Nov 06, 2020
Sell 1.88 M USD
MILLER GEORGE LLOYD
- 6342
296.4147 USD
4 years ago
Nov 06, 2020
Sell 790 K USD
MILLER GEORGE LLOYD
- 2658
297.2833 USD
7 years ago
Oct 17, 2017
Bought 31.5 K USD
ZENNER PATRICK J
+ 335
93.9367 USD
5 years ago
Feb 28, 2019
Bought 5.68 K USD
ZENNER PATRICK J
+ 54
105.1371 USD
5 years ago
Mar 19, 2019
Sell 1.17 K USD
ZENNER PATRICK J
- 11
106.0163 USD
5 years ago
Mar 21, 2019
Sell 3.51 K USD
ZENNER PATRICK J
- 33
106.4856 USD
6 years ago
Jul 31, 2018
Bought 6.3 K USD
ZENNER PATRICK J
+ 57
110.5529 USD
5 years ago
Jul 18, 2019
Sell 2.44 K USD
ZENNER PATRICK J
- 20
121.8342 USD
7 years ago
Nov 10, 2017
Sell 34 K USD
ZENNER PATRICK J
- 335
101.5426 USD
5 years ago
Jul 25, 2019
Sell 6.21 K USD
ZENNER PATRICK J
- 47
132.2151 USD
4 years ago
Jul 28, 2020
Sell 190 K USD
MONTECALVO DAVID A
- 716
266.058 USD
4 years ago
Jul 28, 2020
Sell 2.05 M USD
MONTECALVO DAVID A
- 7773
264.1315 USD
4 years ago
Jul 28, 2020
Sell 764 K USD
MONTECALVO DAVID A
- 2881
265.1292 USD
4 years ago
Jul 28, 2020
Sell 36.7 K USD
MONTECALVO DAVID A
- 138
265.8507 USD
4 years ago
Jul 29, 2020
Sell 886 K USD
MONTECALVO DAVID A
- 3273
270.7038 USD
4 years ago
Jul 28, 2020
Sell 798 K USD
MONTECALVO DAVID A
- 3000
265.9769 USD
4 years ago
May 08, 2020
Sell 200 K USD
Abraham Silji
- 1000
200 USD
4 years ago
May 11, 2020
Sell 204 K USD
Abraham Silji
- 1000
204.5 USD
4 years ago
May 01, 2020
Sell 342 K USD
MILLER GEORGE LLOYD
- 1805
189.3833 USD
4 years ago
Apr 28, 2020
Sell 100 K USD
Abraham Silji
- 500
200.6562 USD
4 years ago
Apr 27, 2020
Sell 508 K USD
Favorite Annette F
- 2600
195.4855 USD
4 years ago
Apr 27, 2020
Sell 1.07 M USD
Favorite Annette F
- 5431
196.6035 USD
4 years ago
Apr 27, 2020
Sell 841 K USD
Favorite Annette F
- 4261
197.483 USD
4 years ago
Apr 27, 2020
Sell 377 K USD
Favorite Annette F
- 1900
198.3841 USD
5 years ago
Apr 30, 2019
Sell 548 K USD
Malone Daniel
- 4458
123.0321 USD
6 years ago
Aug 07, 2018
Sell 2.38 M USD
Flynn Karen
- 20458
116.23 USD
6 years ago
Jun 11, 2018
Sell 486 K USD
Malone Daniel
- 5000
97.24 USD
6 years ago
Jun 08, 2018
Sell 4.12 M USD
FEDERICI WILLIAM J
- 42869
96.09 USD
6 years ago
May 15, 2018
Bought 24.4 K USD
ZENNER PATRICK J
+ 275
88.8884 USD
6 years ago
May 09, 2018
Sell 4.53 M USD
FEDERICI WILLIAM J
- 52000
87.14 USD
6 years ago
Dec 08, 2017
Sell 2.08 M USD
FEDERICI WILLIAM J
- 21000
99.01 USD
7 years ago
May 18, 2017
Sell 5 M USD
FEDERICI WILLIAM J
- 52396
95.4173 USD
7 years ago
May 18, 2017
Sell 250 K USD
FEDERICI WILLIAM J
- 2600
96.0046 USD
7 years ago
May 02, 2017
Sell 385 K USD
Malone Daniel
- 4124
93.3114 USD
7. News
Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp The final trades of the day with the Fast Money traders. youtube.com - 1 day ago
17 Upcoming Dividend Increases This week, 17 companies with an average dividend increase of 8.3% are highlighted, emphasizing consistent dividend growth and outperforming benchmarks. My investment strategy focuses on buying, holding, and adding companies with consistent dividend increases and superior performance compared to benchmarks. The list is created using data from the "U.S. Dividend Champions" spreadsheet and NASDAQ, featuring companies with at least five years of dividend growth. seekingalpha.com - 1 week ago
West to Participate in Upcoming Investor Conferences EXTON, Pa. , Oct. 29, 2024 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences: UBS Global Healthcare Conference in Rancho Pablos Verdes, California, on November 12, 2024 at 3:30 PM PST Jefferies Healthcare Conference in London, UK on Tuesday, November 19, 2024 at 1:00 PM GMT Stephens Annual Investment Conference in Nashville, TN on Thursday, November 21, 2024 at 10:00 AM CST A live audio webcast of these events will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events. prnewswire.com - 2 weeks ago
The Zacks Analyst Blog The Gorman-Rupp, Kontoor Brands, Kontoor Brands and Standex International The Gorman-Rupp, Kontoor Brands, Kontoor Brands and Standex International are included in this Analyst Blog. zacks.com - 2 weeks ago
Buy These 4 Stocks With New Dividend Hikes Amid Market Volatility Stocks like GRC, KTB, WST and SXI recently announced dividend hikes. zacks.com - 2 weeks ago
West Pharmaceutical Services, Inc. (WST) Q3 2024 Earnings Call Transcript West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2024 Results Earnings Conference Call October 24, 2024 9:00 AM ET Company Participants John Sweeney - Vice President, Investor Relations Eric Green - Chairman, President and Chief Executive Officer Bernard Birkett - Senior Vice President, Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Inc. Lawrence Solow - CJS Securities Michael Ryskin - BofA Global Research David Windley - Jefferies Matthew Larew - William Blair & Company Justin Bowers - Deutsche Bank Thomas DeBourcy - Nephron Research Operator Good day and thank you for standing by. Welcome to the Q3 2024 West Pharmaceutical Services Earnings Conference Call. seekingalpha.com - 3 weeks ago
West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend On Thursday, West Pharmaceutical Services, Inc. WST reported adjusted EPS of $1.85, down from $2.16 a year ago, beating the consensus of $1.50. benzinga.com - 3 weeks ago
West Pharmaceutical Stock Gains on Q3 Earnings Beat & Raised Guidance WST's third-quarter results reflect a recovery in the Proprietary Products segment following elevated customer destocking, hurting sales in the second quarter. zacks.com - 3 weeks ago
West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates West Pharmaceutical Services (WST) came out with quarterly earnings of $1.85 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $2.16 per share a year ago. zacks.com - 3 weeks ago
West Pharmaceutical raises annual profit forecast on demand for medical supplies West Pharmaceutical Services raised its annual profit forecast on Thursday, after beating Wall Street estimates for quarterly revenue and profit, banking on rising demand for cartridges and syringes used to manufacture injectable therapies. reuters.com - 3 weeks ago
West to Present on Large Volume Delivery Systems, Administration and Transfer Devices, and Prefillable Syringe Component Expertise at the PDA Conference EXTON, Pa. , Oct. 22, 2024 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation in the 2024 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Phoenix, AZ to showcase its leadership and expertise on industry challenges and trends in packaging and containment.  "With the rise of biologic drugs, injectables are the fastest growing drug segment today, bringing with it new challenges of complex molecules and treatment requirements," says Atul Patel, Vice President, Delivery Devices at West. prnewswire.com - 3 weeks ago
8. Profile Summary

West Pharmaceutical Services, Inc. WST

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 22.8 B
Dividend Yield 0.07%
Description West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Contact 530 Herman O. West Drive, Exton, PA, 19341-0645 https://www.westpharma.com
IPO Date March 17, 1980
Employees 10600
Officers Mr. Bernard J. Birkett Senior Vice President & Chief Financial Officer Mr. Silji Abraham Senior Vice President & Chief Technology Officer Ms. Kimberly Banks MacKay Senior Vice President, General Counsel & Company Secretary Michele Polinsky Vice President of Global Communications Mr. Rudy Poussot Senior Vice President of Strategy & Corporate Development Mr. Eric M. Green Non-Independent Chair of the Board, President & Chief Executive Officer Mr. John P. Sweeney C.F.A. Head of Investor Relations Ms. Cindy Reiss-Clark Senior Vice President & Chief Commercial Officer Mr. Chad R. Winters Vice President, Chief Accounting Officer & Corporate Controller Ms. Annette F. Favorite Chief Human Resources Officer & Senior Vice President